Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04176575 · ClinicalTrials.gov registry record · NA

Balancing Method for Pain Related to Advanced Cancer

A NA study of Metastatic Cancer and Pain, Cancer, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT04176575 is a NA study of Metastatic Cancer and Pain, Cancer that has completed, run by University of Pittsburgh. The registered enrollment target is 6 participants, below the 444-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04176575, a NA study of Metastatic Cancer and Pain, Cancer, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Balancing Method for Pain Related to Advanced Cancer seeks to confirm the benefit of acupuncture for patients with pain related to advanced cancer.

Interventions

  • OTHER Acupuncture

Study Locations (1)

Pennsylvania

  • UPMC Center for Integrative Medicine - Pittsburgh

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2022-07-05
Est. Completion 2024-01-20
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT04176575

The ClinicalTrials.gov registry entry for NCT04176575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 444-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Metastatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.

NCT04176575 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04176575 about?

NCT04176575 is a clinical study titled "Balancing Method for Pain Related to Advanced Cancer". Balancing Method for Pain Related to Advanced Cancer seeks to confirm the benefit of acupuncture for patients with pain related to advanced cancer.

What is the current status of trial NCT04176575?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2022-07-05. Estimated completion is 2024-01-20.

What conditions does trial NCT04176575 study?

This clinical trial studies the following conditions: Metastatic Cancer, Pain, Cancer, Invasive Cancer.

What interventions are being tested in trial NCT04176575?

The interventions under investigation include: Acupuncture (OTHER).

Who is sponsoring clinical trial NCT04176575?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04176575 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metastatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.